Skip to content

FoxBioPath

Active Private limited companyfounded 2025active for 1 yearSenthout 16, 2570 DuffelKBO/BCE: BE 1025.117.675

Lifetime

1 annual account with figures
peak of €83,868 in 2025
€83,868 
peak of €66,668 in 2025
€66,668 
peak of €71,668 in 2025
€71,668 
€32,174 
Board1 name since 2025
1 director
Documentsfilings and deeds
28-06-202633 days before the deadline
2025micro format
Incorporation 07-071 establishment registeredFirst year with figures

Key points

from the 2025 annual accounts

Turnover

≈ €250,000 estimated

The micro format states no turnover.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 11,279 companies had the same profile as FoxBioPath has now. Each dot stands for 29 companies, two years later.

96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,912 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 11,279 companies, not a prediction for FoxBioPath. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 03-07-2025
  • 70 sharesdeed of 07-07-2025
  • 30 sharesdeed of 07-07-2025
Board & ownership

Recent changes

Incorporation Founding capital of €5,000, 100 shares · Founded by and · appointed as director · published on 07-07-2025 · Gazette deed
First establishment Senthout 16, Duffel
All 3 events

Comparable companies

same main activity, similar in size and age
Company
FoxBioPath Duffel €103,842 €83,868 69.0% -
Consultbio Rumst €106,674 €75,189 60.4% -
HYDRICTIS Clavier €121,619 €116,847 78.6% -
ReWrite Leuven €115,374 €63,990 -2.5% -
SHIFT HAPPENS Ghent €62,809 €49,652 69.4% -
ZOOVERY Sint-Genesius-Rode €145,109 €83,823 66.9% -
GDP HEALTH Lasne €70,909 €81,066 79.9% -

These companies have the same main activity as FoxBioPath: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €62,800 and €145,000, founded between 2024 and 2025.

Official details

Source: KBO
Status
Active since 03-07-2025Normal situation
Activity
Research and development on biotechnologyNACE 72101and 2 others
Establishment unit
2.375.947.6922570 Duffel, since 03-07-2025
Financial year end
31 December
Peppol
Reachable
Company details

Annual accounts 2025

€103,842
Filing
Filed on 28-06-2026, 33 days before the end of the filing period
Financials

Insights on FoxBioPath

FoxBioPath has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €71,668 and a net result of €66,668.

Its solvency ranks better than 58% of 666 sector peers (NACE 72) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about FoxBioPath

What is the company number of FoxBioPath?
The company number of FoxBioPath is 1025.117.675. The VAT number is the same number with BE in front: BE 1025.117.675.
Where is FoxBioPath based?
The registered office is at Senthout 16, 2570 Duffel.Company details
What does FoxBioPath do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of FoxBioPath?
FoxBioPath is a private limited company (BV).
When was FoxBioPath founded?
FoxBioPath was founded on 03-07-2025.
Is FoxBioPath still active?
Yes, FoxBioPath is an active enterprise in the KBO register.
What is the turnover of FoxBioPath?
The turnover in financial year 2025 is ≈ €250,000. This figure is estimated from the gross margin of €83,868 and 2,982 comparable companies of the same size. It probably lies between €160,000 and €430,000. It is a rough estimate.Financials
Is FoxBioPath profitable?
In financial year 2025, FoxBioPath made a profit of €66,668.
Where can I find the annual accounts of FoxBioPath?
FoxBioPath filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.